These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

219 related items for PubMed ID: 15842129

  • 1. Cholesterol lowering in diabetes. New evidence supports aggressive LDL-C targets.
    Rosenson RS.
    Postgrad Med; 2005 Apr; 117(4):17-20, 23-7. PubMed ID: 15842129
    [Abstract] [Full Text] [Related]

  • 2. Niacin as a component of combination therapy for dyslipidemia.
    Miller M.
    Mayo Clin Proc; 2003 Jun; 78(6):735-42. PubMed ID: 12934785
    [Abstract] [Full Text] [Related]

  • 3. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ, Watson KE, Talbert RL.
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [Abstract] [Full Text] [Related]

  • 4. Managing dyslipidemia in the high-risk patient.
    Stein EA.
    Am J Cardiol; 2002 Mar 07; 89(5A):50C-57C. PubMed ID: 11900720
    [Abstract] [Full Text] [Related]

  • 5. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M, Roberts A, Davies S, Rees A.
    Drugs; 2004 Mar 07; 64(11):1181-96. PubMed ID: 15161326
    [Abstract] [Full Text] [Related]

  • 6. Identifying patients at risk for coronary heart disease: implications from trials of lipid-lowering drug therapy.
    Isles CG, Paterson JR.
    QJM; 2000 Sep 07; 93(9):567-74. PubMed ID: 10984551
    [Abstract] [Full Text] [Related]

  • 7. Nicotinic acid in the management of dyslipidaemia associated with diabetes and metabolic syndrome: a position paper developed by a European Consensus Panel.
    Shepherd J, Betteridge J, Van Gaal L, European Consensus Panel.
    Curr Med Res Opin; 2005 May 07; 21(5):665-82. PubMed ID: 15969866
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Current lipid management and low cholesterol goal attainment in common daily practice in Spain. The REALITY Study.
    García Ruiz FJ, Marín Ibáñez A, Pérez-Jiménez F, Pintó X, Nocea G, Ahumada C, Alemao E, Yin D, REALITY Study Group.
    Pharmacoeconomics; 2004 May 07; 22 Suppl 3():1-12. PubMed ID: 15669149
    [Abstract] [Full Text] [Related]

  • 10. Pharmacotherapy of dyslipidemia.
    McKenney JM.
    Cardiovasc Drugs Ther; 2001 Sep 07; 15(5):413-22. PubMed ID: 11855660
    [Abstract] [Full Text] [Related]

  • 11. What does the future hold for niacin as a treatment for hyperlipidaemia and cardiovascular disease?
    Ahmed MH.
    J Cardiovasc Med (Hagerstown); 2010 Nov 07; 11(11):858-60. PubMed ID: 20686417
    [Abstract] [Full Text] [Related]

  • 12. Diabetic dyslipidemia.
    Kreisberg RA.
    Am J Cardiol; 1998 Dec 17; 82(12A):67U-73U; discussion 85U-86U. PubMed ID: 9915665
    [Abstract] [Full Text] [Related]

  • 13. Combination therapy for elevated low-density lipoprotein cholesterol: the key to coronary artery disease risk reduction.
    McKenney J.
    Am J Cardiol; 2002 Nov 20; 90(10B):8K-20K. PubMed ID: 12467936
    [Abstract] [Full Text] [Related]

  • 14. Use of combination therapy for dyslipidemia: a lipid clinic approach.
    Brown AS.
    Am J Cardiol; 2002 Nov 20; 90(10B):44K-49K. PubMed ID: 12467939
    [Abstract] [Full Text] [Related]

  • 15. Treatment of dyslipidaemia in high-risk patients: too little, too late.
    Barter P.
    Int J Clin Pract Suppl; 2002 Jul 20; (130):15-9. PubMed ID: 12296602
    [Abstract] [Full Text] [Related]

  • 16. Achievement of low-density lipoprotein cholesterol goals: new strategies to address new guidelines.
    Illingworth DR.
    Cardiol Clin; 2003 Aug 20; 21(3):363-75. PubMed ID: 14621451
    [Abstract] [Full Text] [Related]

  • 17. [Overviews of fibrate].
    Tada N.
    Nihon Rinsho; 2001 Mar 20; 59 Suppl 3():609-17. PubMed ID: 11347141
    [No Abstract] [Full Text] [Related]

  • 18. Management of hypercholesterolaemia in the patient with diabetes.
    Packard C, Olsson AG.
    Int J Clin Pract Suppl; 2002 Jul 20; (130):27-32. PubMed ID: 12296606
    [Abstract] [Full Text] [Related]

  • 19. Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.
    Nesto RW.
    Am J Cardiovasc Drugs; 2005 Jul 20; 5(6):379-87. PubMed ID: 16259526
    [Abstract] [Full Text] [Related]

  • 20. The relative role of low-density lipoprotein cholesterol and high-density lipoprotein cholesterol in coronary artery disease: evidence from large-scale statin and fibrate trials.
    Sacks FM.
    Am J Cardiol; 2001 Dec 20; 88(12A):14N-18N. PubMed ID: 11788125
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.